People: Zimmer Holdings Inc (ZMH)

ZMH on New York Consolidated

99.45USD
28 Aug 2014
Price Change (% chg)

$-0.33 (-0.33%)
Prev Close
$99.78
Open
$99.31
Day's High
$99.65
Day's Low
$99.00
Volume
715,412
Avg. Vol
1,141,673
52-wk High
$108.33
52-wk Low
$78.00

Search Stocks

Summary

Name Age Since Current Position

John McGoldrick

73 2007 Independent Non-Executive Chairman of the Board

David Dvorak

50 2007 President, Chief Executive Officer, Director

James Crines

54 2007 Chief Financial Officer, Executive Vice President - Finance

Joseph Cucolo

54 2012 President, Americas Sales

Katarzyna Mazur-Hofsaess

50 2013 President, Europe, Middle East and Africa

Stephen Ooi

60 2005 President, Asia Pacific

Chad Phipps

42 2007 Senior Vice President, General Counsel, Secretary

Derek Davis

45 2007 Vice President - Finance, Chief Accounting Officer, Corporate Controller

Christopher Begley

61 2012 Independent Director

Betsy Bernard

59 2009 Independent Director

Paul Bisaro

53 2013 Independent Director

Gail Boudreaux

53 2012 Independent Director

Larry Glasscock

66 2001 Independent Director

Robert Hagemann

57 2008 Independent Director

Arthur Higgins

58 2007 Independent Director

Cecil Pickett

67 2008 Independent Director

Robert Marshall

Vice President - Investor Relations, Treasurer

Biographies

Name Description

John McGoldrick

Mr. John L. McGoldrick is an Independent Non-Executive Chairman of the Board of Zimmer Holdings, Inc. He is Special Advisor, International AIDS Vaccine Initiative (“IAVI”) since September 2009. Senior Vice President, External Strategy Development, IAVI, from May 2006 until September 2009. Chairman, Governor’s Higher Education Council, since April 2011. Chairman, Association of State Colleges and Universities (NJ) from January 2009 until June 2011. Previously, Mr. McGoldrick served as Executive Vice President of Bristol-Myers Squibb Company from October 2005 until his retirement in April 2006. He held the position of Executive Vice President and General Counsel of Bristol-Myers Squibb from January 2000 to October 2005. Prior to that, he held the position of Senior Vice President, General Counsel from January 1995 and President, Medical Devices Group from December 1998 to January 2000. Previously, Mr. McGoldrick was a Senior Partner with the law firm of McCarter & English. He is a graduate of Harvard College and the Harvard Law School.

David Dvorak

Mr. David C. Dvorak is President, Chief Executive Officer, Director of Zimmer Holdings, Inc. He has been President and Chief Executive Officer of the company since May 1, 2007. Prior to that, Mr. Dvorak served as Group President, Global Businesses and Chief Legal Officer from December 2005. From October 2003 to December 2005, Mr. Dvorak served as Executive Vice President, Corporate Services, Chief Counsel and Secretary, as well as Chief Compliance Officer. Mr. Dvorak was appointed Corporate Secretary in February 2003. He joined Zimmer in December 2001 as Senior Vice President, Corporate Affairs and General Counsel. Mr. Dvorak earned a B.S. in Business Administration (Finance) from Miami University (Ohio) and a J.D., magna cum laude, from Case Western Reserve University School of Law. He is chairman of the board of directors of AdvaMed.

James Crines

Mr. James T. Crines is Chief Financial Officer, Executive Vice President - Finance of Zimmer Holdings, Inc., since May 1, 2007. From December 2005 to April 2007, he served as Senior Vice President, Finance, Operations and Corporate Controller and Chief Accounting Officer. Prior to that, he had served as Senior Vice President, Finance/Controller and Information Technology since October 2003. Mr. Crines joined Zimmer in 1995.

Joseph Cucolo

Mr. Joseph A. Cucolo is President, Americas Sales of Zimmer Holdings, Inc., since September 2012. He is responsible for sales and management of the direct and indirect sales channels in the Americas region, including the United States, Canada and Latin America. From 1997 until he joined Zimmer as President, Americas Sales, Mr. Cucolo was sole owner and President of Zimmer New England, Inc., an independent third-party distributor of Zimmer products in the northeast region of the United States. Prior to that, Mr. Cucolo was employed by Zimmer as a sales representative and territory manager in the New York area from 1987 to 1997.

Katarzyna Mazur-Hofsaess

Dr. Katarzyna Mazur-Hofsaess, M.D., Ph.D. is President, Europe, Middle East and Africa of Zimmer Holdings, Inc. Dr. Mazur-Hofsaess was appointed President, Europe, Middle East and Africa in April 2013. She is responsible for the sales, marketing and distribution of products in the European, Middle Eastern and African (EMEA) regions. Dr. Mazur-Hofsaess joined Zimmer in February 2010 as Senior Vice President, EMEA Sales and Marketing and was appointed President, EMEA Reconstructive in February 2012. She has approximately 20 years’ experience within the pharmaceutical, diagnostics and medical device sectors. Prior to joining Zimmer, Dr. Mazur-Hofsaess served as Vice President, Diagnostics – Europe of Abbott Laboratories from 2001.

Stephen Ooi

Mr. Stephen H. L. Ooi is President, Asia Pacific of Zimmer Holdings, Inc., since December 2005. He is responsible for the sales, marketing and distribution of products in the Asia Pacific region. Prior to that, he had served as President, Australasia since September 2003. Mr. Ooi joined Zimmer in 1986.

Chad Phipps

Mr. Chad F. Phipps is Senior Vice President, General Counsel, Secretary of Zimmer Holdings, Inc., since May 2007. He has global responsibility for legal affairs and he serves as Secretary to the Board of Directors. Mr. Phipps oversees Government Affairs, Corporate Marketing and Communications and Public Relations activities. From December 2005 to May 2007, he served as Associate General Counsel and Corporate Secretary. Prior to that, he had served as Associate Counsel and Assistant Secretary since September 2003. Mr. Phipps joined Zimmer in 2003.

Derek Davis

Mr. Derek M. Davis is Vice President - Finance, Chief Accounting Officer, Corporate Controller of Zimmer Holdings, Inc., since May 2007. He has responsibility for internal and external reporting, planning and analysis, and corporate and business unit accounting. From March 2006 to May 2007, he served as Director, Financial Planning and Accounting. Prior to that, he had served as Director, Finance, Operations and Logistics since December 2003. Mr. Davis joined Zimmer in 2003.

Christopher Begley

Mr. Christopher B. Begley is an Independent Director of Zimmer Holdings, Inc. He is Retired Executive Chairman and Chief Executive Officer of Hospira, Inc. Mr. Begley served as Executive Chairman of the Board of Hospira from May 2007 until January 2012. He also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. He serves as non-executive chairman of the board of Hillshire Brands Company and as a director of DeVry Education Group Inc. and Hanger, Inc. Mr. Begley previously served as a director of Sara Lee Corporation, the Advanced Medical Technology Association (“AdvaMed”), the medical device industry’s trade association, and the National Center for Healthcare Leadership. He earned a bachelor’s degree from Western Illinois University and a master’s degree in business administration from Northern Illinois University. Board Committees: Audit Committee and Research, Innovation and Technology Committee.

Betsy Bernard

Ms. Betsy J. Bernard is an Independent Director of Zimmer Holdings, Inc. She is President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard serves as a director of Principal Financial Group, Inc. and previously served as a director of Telular Corporation and BearingPoint, Inc. within the last five years. Ms. Bernard received a B.A. degree from St. Lawrence University, a master’s in business administration from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program. Board Committees: Compensation and Management Development Committee and Corporate Governance Committee (Chair).

Paul Bisaro

Mr. Paul M. Bisaro is an Independent Director of Zimmer Holdings, Inc. Mr. Bisaro has been Chairman, President and Chief Executive Officer of Actavis plc since October 2013. Mr. Bisaro has served as President and Chief Executive Officer and a member of the Board of Directors of Actavis (formerly Watson Pharmaceuticals) since 2007. He was appointed Chairman of the Board in October 2013. Prior to joining Actavis, Mr. Bisaro served as President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc. from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr. Prior to joining Barr, Mr. Bisaro was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds, from 1989 to 1992. Mr. Bisaro holds an undergraduate degree in General Studies from the University of Michigan and a Juris Doctor from Catholic University of America in Washington, D.C. Board Committees: Compensation and Management Development Committee and Corporate Governance Committee.

Gail Boudreaux

Ms. Gail Koziara Boudreaux is an Independent Director of Zimmer Holdings, Inc. Ms. Boudreaux is Chief Executive Officer of UnitedHealthcare since January 2011 and Executive Vice President of UnitedHealth Group since May 2008. From 2005 to 2008, Ms. Boudreaux served as Executive Vice President External Operations for Health Care Services Corporation (“HCSC”), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC. Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance. Ms. Boudreaux earned a master's degree in business administration from Columbia Business School and a bachelor's degree in psychology from Dartmouth College. She serves as a director of Xcel Energy Inc. and previously served as a director of Genzyme Corporation.

Larry Glasscock

Mr. Larry C. Glasscock is an Independent Director of Zimmer Holdings, Inc. He was Chairman of WellPoint, Inc. from November 2005 until his retirement in March 2010. Mr. Glasscock also served as President and Chief Executive Officer of WellPoint, Inc. from November 2004 (following the merger between Anthem, Inc. and WellPoint Health Networks Inc.) until his retirement from day-to-day operations in June 2007. Prior to Anthem’s merger with WellPoint Health Networks in November 2004, Mr. Glasscock had served as Anthem’s President and Chief Executive Officer since 2001 and also as Anthem’s Chairman since 2003. Mr. Glasscock earned a B.B.A. from Cleveland State University. He also completed the Commercial Bank Management Program at Columbia University. Mr. Glasscock serves as a director of Simon Property Group, Inc. and Sysco Corporation and previously served as a director of Sprint Nextel Corporation and WellPoint, Inc.

Robert Hagemann

Mr. Robert A. Hagemann is an Independent Director of Zimmer Holdings, Inc. He is Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated since August 1998. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, where he held a variety of senior financial positions before being named Vice President and Corporate Controller of Quest Diagnostics in 1996. In March 2013, Mr. Hagemann announced that he will leave Quest Diagnostics effective May 31, 2013. Prior to joining Corning, Mr. Hagemann was employed by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Arthur Higgins

Mr. Arthur J. Higgins is an Independent Director of Zimmer Holdings, Inc. He is Consultant, Blackstone Healthcare Partners of The Blackstone Group, since June 2010. Prior to that, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He is a past member of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), a past member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and past President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Mr. Higgins is a director of Resverlogix Corp. and Ecolab Inc. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Cecil Pickett

Dr. Cecil B. Pickett, Ph.D., is an Independent Director of Zimmer Holdings, Inc. He is President, Research and Development of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received his B.Sc. in biology from California State University at Hayward and his Ph.D. in cell biology from University of California at Los Angeles. He is also a member of the Institute of Medicine of The National Academy of Sciences. Dr. Pickett previously served as a director of Biogen Idec.

Robert Marshall

Options Compensation

Search Stocks